Overview

Clinical Microbiology Market Introduction:

Global Clinical Microbiology Market is estimated to value over USD 5.9 billion by 2027 end and register a CAGR of over 6.2% during the forecast period 2020 to 2027.

Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth.

Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth.

The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions.

Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen.

Clinical Microbiology Market Segmentation:

By Application

Pharmaceutical Applications
Food Testing Applications
Clinical Applications
Energy Applications
Chemical & Material Manufacturing Applications
Environmental Applications

By Product

Instruments
Laboratory Instruments
Incubators
Gram Stainers
Bacterial Colony Counters
Autoclave Sterilizers
Microbial Air Samplers
Anaerobic Culture Systems
Petri Dish Fillers
Blood Culture Systems
Microbial Culture Systems
Other Laboratory Instruments
Microbiology Analyzers
Molecular Diagnostic Instruments
Microscopes
Mass Spectrometers
Reagents
Pathogen-Specific Kits
General Reagents

By Indication

Respiratory Diseases
Bloodstream Infections
Gastrointestinal Diseases
Sexually Transmitted Diseases
Urinary Tract Infections
Periodontal Diseases
Other Indications

By End User

Hospitals & Diagnostic Centres
Custom Lab Service Providers
Academic & Research Institutes

By Region

North America
Europe
Asia Pacific
Rest of the World

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global clinical microbiology market by application, by product, by indication, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies